Hookworm is an intestinal parasite most commonly found in tropical and subtropical climates worldwide, particularly in Africa, South East Asia, the Western Pacific, Latin America and the Mediterranean. Hookworm is one of three members of a family of parasites known as the soil-transmitted helminths (STHs) and affects more than 700 million people across the globe. Left untreated, hookworm causes internal blood loss leading to iron-deficiency anemia and protein malnutrition, particularly in pregnant women and children. Chronic hookworm infection in children contributes to physical and intellectual impairment, learning difficulties and poor school performance. Hookworm is a serious global concern contributing to an estimated 43 percent reduction in future wage earnings in affected areas.
Hookworm transmission is a complex, repetitive cycle. Hookworm larvae are found in human feces and transmitted to humans from contaminated soil through the skin, usually due to walking barefoot, or by accidentally ingesting contaminated soil. Once inside the body, larvae are carried through the bloodstream to the lungs and mouth where they are swallowed, digested and passed to the small intestine. The larvae mature into half-inch-long worms which attach themselves to the intestinal wall and feed on human blood. Adult worms mate and hatch thousands of eggs, which are passed into the feces of the human host. If the feces come into contact with soil under the right conditions, the eggs hatch into larvae and are re-transmitted to humans, beginning the cycle again.
There are two common species of hookworm, Necator americanus and Ancylostoma duodenale. Hookworm transmission requires the development of eggs into larvae in soil, and the infection cannot be spread through personal contact.
- Warm, tropical or sub-tropical environments
- Areas with poor or improper sanitation management
- Pregnant women and women of childbearing age
- Pre-school and school-age children
- Farmers and others in contact with contaminated soil
- Itching or rash where contaminated soil has touched the skin
- Abdominal pain
- Weight loss and/or loss of appetite
- Extreme fatigue and weakness
- Intestinal blood loss resulting in anemia and/or malnutrition
- Hookworm larvae enter the body through the skin and find their way to the small intestine. There, they mature into adult worms by attaching themselves to the intestinal wall and feeding on human blood. As the worms feed, they cause severe internal bleeding, leading to abdominal pain and diarrhea, anemia and eventual malnutrition.
- Education on sanitation and hygiene, specifically regarding the proper use of latrines and shoe-wearing
- Anthelminthic drugs albendazole (Albenza) or mebendazole (Vermox) on an annual basis
- 200 million tablets of mebendazole donated per year by Johnson & Johnson until 2020
- 1 billion tablets of Albendazole donated per year from GlaxoSmithKline. Additional need available for $US 0.02 per pill
- The Sabin Vaccine Institute Product Development Partnership (Sabin PDP) is working to develop a vaccine to prevent hookworm infection and eliminate reliance on current drug therapies; development is currently in a Phase I clinical trial
- 700 million people worldwide, including 44 million pregnant women
- Tropical or sub-tropical environments in poverty-stricken areas of Africa, Latin America, Southeast Asia and China
- World’s leading cause of anemia and protein malnutrition, particularly in pregnant women and children
- Major cause of stunting in children; causes intellectual and cognitive deficits
- Children with hookworm have shown a 23 percent drop in school attendance
- “Deworming” (treating hookworm) has been shown to be the most cost-effective mechanism to improve school attendance
- Pregnant women with hookworm are at high risk for low birth-weight babies and poor milk production, and their infants have higher rates of malnutrition and mortality
- Pregnant women who develop anemia are three and a half times more likely to die in childbirth
Efforts at Control
The most effective prevention method for controlling chronic hookworm infection includes both proper sanitation management efforts and educational campaigns aimed at the use of latrines. In addition, two drugs are available to treat active hookworm infection, Albendazole and Mebendazole. In 2001, the World Health Organization adopted a resolution aimed at the deworming of 75 percent of all at-risk school-age children by 2010, the largest public health program ever attempted to date. The Sabin Vaccine Institute is developing a hookworm vaccine which is currently in a Phase I clinical trial. The 2012 WHO Road Map added 75% coverage of pre-school-age children.